產(chǎn)品中心
Product Center
熱門搜索:
Fitzgerald Industries International代理
Envirologix 轉(zhuǎn)基因快速檢測(cè)試紙
Epitomics現(xiàn)貨抗體目錄
ABgene代理30
EVE™ Slide(EVE細(xì)胞計(jì)數(shù)板)
Cayman Chemical 特約代理
法國(guó)ID-VET
Sinobio公司產(chǎn)品介紹
美國(guó)Sutter 玻璃毛坯 BF100-50-10
genview
D12079BWestern Diet(高純度飼料)
polysciences公司中國(guó)總代理
TEAA Solution(貨號(hào):553303;SP5890)
LSPN-50ABMI公司LYSOSTAPHIN中國(guó)總代理
Abcam代理
天然小鼠補(bǔ)體C1q蛋白
當(dāng)前位置:首頁(yè)
產(chǎn)品中心
代理品牌
國(guó)際品牌
unitedbiomedical公司代理

unitedbiomedical公司代理
產(chǎn)品簡(jiǎn)介
UBI is a privay held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
Our product pipeline is filled with our new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, and Allergy, along with a portfolio of animal health diseases. These products are based on our proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies. Our platform technologies are also being used to develop a line of biosimilar versions of widely used protein and antibody drugs whose patents are about to expire.
UBI’s proprietary designer peptide technology has been used to produce a line of blood screening diagnostics and the first successfully commercialized synthetic peptide vaccine. Additional revenue streams are generated from pharmaceutical contract manufacturing by our subsidiary UBI-Asia and various sponsorships in product development.
Catalog # 600441, UBI® HIV-1/2 EIA kit, 192 tests
Catalog # 600061, UBI® HCV EIA kit, 192 tests
Catalog # 600318, UBI® HCV EIA kit, 576 tests
PUBLICATION ON UBI® FMDV NS ELISA (SWINE)